Abstract:Background: Immune checkpoint blockade (ICB) therapies have achieved great promising results in clinics. However, a large proportion of the patients do not respond to these therapies. Therefore, it is essential to develop new immunotherapy for colorectal cancer. Recent studies have revealed the important roles of tumor-infiltrating cytotoxic T lymphocytes (CTL) in enhancing the immunosensitivity of cancer cells to ICB. Here, we identified that IFI35 induced highly proliferative and cytotoxic states of CD8+ T cells, as well as boosted anti-tumor immunotherapy efficacy for CRC.Methods: In this study, we characterized that the expression of IFI35 is associated with the activation and cytotoxicity of CD8+ T cells by analyzing the public TCGA and proteomic databases. Then we engineered IFI35 expressing murine colon cancer cells and tested their roles on anti-tumor immunity in both immunodeficient and immunocompetent mouse models. Flow cytometry and immunohistochemistry were applied to assess the immune microenvironment. Western blot analysis was used to identify the potential down-streaming signaling pathway regulated by IFI35. We further investigated the efficacy of the IFI35 in combination with various immunotherapeutic treatments. Findings: The transcriptional and proteomic analysis of the activation and cytotoxicity of CD8+ T cells in human cancer samples demonstrated that IFI35 expression is associated with increased CD8+ T cell infiltration and predicted a good outcome in colorectal cancer. The number and cytotoxicity of CD8+ T cells were significantly increased in IFI35-overexpressing tumors. Mechanistically, we identified that the IFNg-STAT1-IRF7 signal axis stimulated IFI35 expression, and tumor-secreted IFI35 promoted the proliferation and cytotoxicity of CD8+ T cells by activating the PI3K/mTOR/AKT signaling pathway in vitro. Furthermore, IFI35 sensitized colorectal cancer cells to immune therapy.Interpretation: Our results emphasized that IFI35 induced a robust expansion of activated CD8+ T cells in colorectal cancer. And it may be a promising biomarker for predicting prognosis and immunotherapy in CRC. Funding Information: This work was supported by the Key-Area Research and Development Program of Guangdong Province (No.2019B020229002), Science and Technology Planning Project of Guangzhou (No. 201902020009, SL2023A04J01608).Declaration of Interests: Authors declare that they have no competing interests.Ethics Approval Statement: All experiments were approved by the Research Ethical Committee of the Sixth Affiliated Hospital of Sun Yet-sen University and in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory animals.

Interferon- inducible protein 30 promotes the epithelial-mesenchymal transition-like phenotype and chemoresistance by activating EGFR/AKT/GSK3/-catenin pathway in glioma

Interferon‐γ Inducible Protein 30 Promotes the Epithelial–mesenchymal Transition‐like Phenotype and Chemoresistance by Activating EGFR/AKT/GSK3β/β‐catenin Pathway in Glioma

Identification of IFN-Induced Transmembrane Protein 1 with Prognostic Value in Pancreatic Cancer Using Network Module-Based Analysis.

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma

IFI30 as a prognostic biomarker and correlation with immune infiltrates in glioma

A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma.

IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer

The Crosstalk between the EGFR and IFN-γ Pathways and Synergistic Roles in Survival Prediction and Immune Escape in Gliomas

IFITM3 promotes glioblastoma stem cell-mediated angiogenesis via regulating JAK/STAT3/bFGF signaling pathway

miR-30c plays diagnostic and prognostic roles and mediates epithelial–mesenchymal transition (EMT) and proliferation of gliomas by affecting Notch1

The Role of IFITM3 in the Growth and Migration of Human Glioma Cells

IFN-γ Induces Epithelial-to-mesenchymal Transition of Cancer Cells Via an Unique Microrna Processing

IFITM10 Enhance Tumor Angiogenesis and Promotes Cancer Progression through STAT3 Activation

Human Fibulin-3 Protein Variant Expresses Anti-Cancer Effects in the Malignant Glioma Extracellular Compartment in Intracranial Xenograft Models

MicroRNA-30e* Promotes Human Glioma Cell Invasiveness in an Orthotopic Xenotransplantation Model by Disrupting the NF-κB/IκBα Negative Feedback Loop

Interferon Alpha-Inducible Protein 27 Promotes Epithelial–mesenchymal Transition and Induces Ovarian Tumorigenicity and Stemness

IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling

Ifn Gamma-Induced Ifit5 Promotes Epithelial-To-Mesenchymal Transition In Prostate Cancer Via Mirna Processing

IFITM3/STAT3 Axis Promotes Glioma Cells Invasion and is Modulated by TGF-β

Tumor-Secreted IFI35 Promotes Proliferation and Cytotoxic Activity of CD8+ T Cells&nbsp;Through PI3K/Akt/mTOR Signaling Pathway in Colorectal Cancer

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy